mBioMicrobiologyPeer-reviewed journal article
CD4 downregulation precedes Env expression and protects HIV-1-infected cells from ADCC mediated by non-neutralizing antibodies
Jonathan RichardiD, Gérémy SannieriD, Li ZhuiD, Jérémie PrévostiD, Lorie MarchittoiD, Mehdi BenlarbiiD, Guillaume Beaudoin-BussièresiD, Hongil KimiD, Yaping SuniD, Debashree ChatterjeeiD, Halima Medjahed, Catherine BourassaiD, Gloria-Gabrielle Ortega-Delgado, Mathieu DubéiD, Frank KirchhoffiD, Beatrice H. HahniD, Priti KumariD, D. E. KaufmanniD, Andrés FinziiD
Abstract
HIV-1 envelope glycoprotein (Env) conformation substantially impacts antibody-dependent cellular cytotoxicity (ADCC). Envs from primary HIV-1 isolates adopt a prefusion "closed" conformation, which is targeted by broadly-neutralizing antibodies (bnAbs). CD4 binding drives Env into more "open" conformations, which are recognized by non-neutralizing Abs (nnAbs). To better understand Env-Ab and Env-CD4 interaction in CD4+ T cells infected with HIV-1, we simultaneously measured antibody binding and HIV-1 mRNA expression using multiparametric flow cytometry and RNA-flow fluorescent in situ hybridization (FISH) techniques. We observed that env mRNA is almost exclusively expressed by HIV-1 productively-infected cells that already downmodulated CD4. This suggest that CD4 downmodulation precedes env mRNA expression. Consequently, productively-infected cells express "closed" Envs on their surface, which renders them resistant to nnAbs. Cells recognized by nnAbs were all env mRNA negative, indicating Ab binding through shed gp120 or virions attached to their surface. Consistent with these findings, treatment of HIV-1 infected humanized mice with the ADCC mediating nnAb A32 failed to lower viral replication or reduce the size of the viral reservoir. These findings confirm the resistance of productively-infected CD4+ T cells to nnAbs-mediated ADCC and question the rationale of immunotherapy approaches using this strategy. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=199 SRC="FIGDIR/small/592003v2_ufig1.gif" ALT="Figure 1"> View larger version (30K): org.highwire.dtl.DTLVardef@1c34d91org.highwire.dtl.DTLVardef@11975c0org.highwire.dtl.DTLVardef@81b5beorg.highwire.dtl.DTLVardef@1c2e0b2_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: flow cytometry
- research focus: host-pathogen & immune response
- approach: experimental assay
- Citations
- 17
- FWCI
- 2.62
- Field percentile
- top 10%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The combination of three CD4-induced antibodies targeting highly conserved Env regions with a small CD4-mimetic achieves potent ADCC activity
Lorie Marchitto, Jonathan Richard, … Andrés Finzi·Journal of VirologyPeer-reviewed·Sep 9, 2024
- The HIV-1 envelope cytoplasmic tail protects infected cells from ADCC by downregulating CD4
Alexandra Tauzin, Étienne Bélanger, … Andrés Finzi·mBioPeer-reviewed·Sep 8, 2025
- Small CD4 mimetics sensitize HIV-1-infected macrophages to antibody-dependent cellular cytotoxicity
A. Laumaea, L. Marchitto, … A. Finzi·bioRxiv·Jun 30, 2022
- Nef and Vpu protect infected cells from ADCP mediated by plasma from people with HIV-1
Étienne Bélanger, Alexandra Tauzin, … Andrés Finzi·mBioPeer-reviewed·Jul 29, 2026
- Across functional boundaries: making non-neutralizing antibodies to neutralize HIV-1 and mediate Fc-mediated effector killing of infected cells
J. Richard, D. Nguyen, … M. Pazgier·bioRxiv·Aug 13, 2021
- The asymmetric opening of HIV-1 Env by a potent CD4 mimetic enables anti-coreceptor binding site antibodies to mediate ADCC
Jonathan Richard, Michael W. Grunst, … Andrés Finzi·Nature CommunicationsPeer-reviewed·Dec 1, 2025